897983

Fresenius Kabi USA, LLC — FEI 3002733956

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 6, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lake Zurich, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)